Published in Hepatology on May 01, 1993
Effect of hepatic iron concentration reduction on hepatic fibrosis and damage in rats with cholestatic liver disease. World J Gastroenterol (2006) 0.93
Experimental obstructive cholestasis: the wound-like inflammatory liver response. Fibrogenesis Tissue Repair (2008) 0.91
Effects of combined anisodamine and neostigmine treatment on the inflammatory response and liver regeneration of obstructive jaundice rats after hepatectomy. Biomed Res Int (2014) 0.81
Reactive oxygen species and vascular cell adhesion molecule-1 in distant organ failure following bile duct obstruction in mice. Dig Dis Sci (2002) 0.76
Clinicopathological features of choledocholithiasis patients with high aminotransferase levels without cholangitis: Prospective comparative study. Medicine (Baltimore) (2016) 0.75
The Impact of Sterile Inflammation in Acute Liver Injury. J Clin Transl Res (2017) 0.75
Dysfunction of Circulating Polymorphonuclear Leukocytes and Monocytes in Ambulatory Cirrhotics Predicts Patient Outcome. Dig Dis Sci (2016) 0.75
The need for liver transplantation: a nationwide estimate based on consensus review. Lancet (1995) 2.58
Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR. J Clin Microbiol (1998) 2.42
Reduction of blood culture contamination rate by an educational intervention. Clin Microbiol Infect (2006) 2.25
Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect (2003) 1.85
Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax (1996) 1.78
Epidemiology and ethnic distribution of multidrug-resistant tuberculosis in southern Israel, 1992-1997: the impact of immigration. Chest (2000) 1.55
Abnormalities in bilirubin and liver enzyme levels in adult patients with bacteremia. A prospective study. Arch Intern Med (1989) 1.53
Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients. Chest (1996) 1.48
Fulminant non--A-G viral hepatitis leading to liver transplantation. Arch Intern Med (2000) 1.39
Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol (1985) 1.28
Mobility of human red blood cells of different age groups in an electric field. Blood (1969) 1.26
Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia. Scand J Infect Dis (2001) 1.20
Induction of the respiratory burst in HL-60 cells. Correlation of function and protein expression. J Immunol (1990) 1.18
Enterococcus hirae septicemia in a patient with end-stage renal disease undergoing hemodialysis. Eur J Clin Microbiol Infect Dis (1998) 1.18
Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients. Respiration (1996) 1.14
Morphological and cytochemical observations on cells of the hemopoietic system of Agama stellio (Linnaeus). A comparative study. Isr J Med Sci (1970) 1.09
Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology (1986) 1.09
Lamivudine treatment for acute severe hepatitis B: a pilot study. Liver Int (2004) 1.07
Adult respiratory distress syndrome and pancreatitis as complications of falciparum malaria. Crit Care Med (1988) 1.07
Cell wall synthesis and initiation of deoxyribonucleic acid replication in Bacillus subtilis. J Bacteriol (1981) 1.05
Stimulation of oxidative burst in human monocytes by lipoteichoic acids. Infect Immun (1990) 1.01
Autoimmune hepatitis in a genetically susceptible patient: is it triggered by acute viral hepatitis A? Dig Dis Sci (1999) 1.01
Trypsinlike enzymes from dormant and germinated spores of Bacillus cereus T and their possible involvement in germination. J Bacteriol (1985) 0.97
Interaction of flow and resistance in maintenance of portal hypertension in a rat model. Am J Physiol (1986) 0.97
Effect of inhibitors of trypsin-like proteolytic enzymes Bacillus cereus T spore germination. J Bacteriol (1983) 0.96
Pneumococcal infections among immunised and splenectomised patients in Israel. J Infect (1985) 0.96
Cloning and expression of Bacillus thuringiensis israelensis delta-endotoxin DNA in B. sphaericus. J Invertebr Pathol (1991) 0.96
Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings. Transfus Med (2007) 0.95
Resporulation of outgrowing Bacillus subtilis spores. J Bacteriol (1976) 0.95
Nelfinavir-induced insulin resistance is associated with impaired plasma membrane recruitment of the PI 3-kinase effectors Akt/PKB and PKC-zeta. Diabetologia (2004) 0.95
The possible involvement of trypsin-like enzymes in germination of spores of Bacillus cereus T and Bacillus subtilis 168. J Gen Microbiol (1991) 0.94
Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum (1998) 0.94
The epidemiology of community-acquired pneumonia among hospitalized adults. J Infect (1997) 0.94
Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel, 1991-1995. Eur J Clin Microbiol Infect Dis (1997) 0.93
The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes. Diabetes (2001) 0.93
Community-acquired pneumonia in old age: a prospective study of 91 patients admitted from home. Age Ageing (1997) 0.92
Mediterranean spotted fever in an American woman. Arch Intern Med (1985) 0.92
Impact of regular attendance by infectious disease specialists on the management of hospitalised adults with community-acquired febrile syndromes. Clin Microbiol Infect (2004) 0.92
Hepatitis B and C viruses serology in patients with SLE. Lupus (1997) 0.92
Evidence against high contagiousness of Lassa fever. Trans R Soc Trop Med Hyg (1988) 0.91
Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients. Infection (1996) 0.91
Urinary tract infections caused by multi-drug resistant Proteus mirabilis: Risk factors and clinical outcomes. Infection (2009) 0.90
Hyperglycemia and uric acid. Isr J Med Sci (1970) 0.90
Prospective study on symptomatic versus asymptomatic infections and serological response to spotted fever group rickettsiae in two rural sites in the Negev (southern Israel). Ann N Y Acad Sci (1990) 0.90
Microparticle agglutination versus antibody-capture enzyme immunoassay for diagnosis of community-acquired Mycoplasma pneumoniae pneumonia. Eur J Clin Microbiol Infect Dis (1995) 0.90
Hemodynamic studies in long- and short-term portal hypertensive rats: the relation to systemic glucagon levels. Hepatology (1986) 0.89
Hospital-acquired brevundimonas vesicularis septicaemia following open-heart surgery: case report and literature review. Scand J Infect Dis (2000) 0.89
Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Arch Intern Med (1997) 0.89
Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy. J Infect (1999) 0.88
Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active anti-retroviral therapy in a patient with human immunodeficiency virus infection. Isr Med Assoc J (2001) 0.88
HCV antibodies in saliva and urine. J Med Virol (1998) 0.88
A syndrome of inappropriate ADH secretion induced by cyclothiazide. J Clin Pharmacol New Drugs (1972) 0.88
Independence of Bacillus subtilis spore outgrowth from DNA synthesis. J Bacteriol (1978) 0.88
Glucagon and insulin metabolism in a portal-hypertensive rat model. Am J Physiol (1987) 0.88
Virus-specific serum IgG, IgM, and IgA antibodies in cytomegalovirus mononucleosis patients as determined by immunoblotting technique. J Med Virol (1987) 0.87
IL-1beta and IL-6 in community-acquired pneumonia: bacteremic pneumococcal pneumonia versus Mycoplasma pneumoniae pneumonia. Infection (1997) 0.87
Clonal variability of group B Streptococcus among different groups of carriers in southern Israel. Eur J Clin Microbiol Infect Dis (2006) 0.86
Specific inhibition of outgrowth of Bacillus subtilis spores by novobiocin. J Bacteriol (1979) 0.86
Polymicrobial central nervous system infection in the acquired immunodeficiency syndrome. J Neurol Neurosurg Psychiatry (1988) 0.86
Ciprofloxacin in the treatment of nosocomial multiply resistant Acinetobacter calcoaceticus bacteremia. Infection (1990) 0.85
Extrapulmonary tuberculosis in an immigrant society: clinical and demographic aspects of 92 cases. Rev Infect Dis (1991) 0.85
Impact of pooling on accuracy of hepatitis B virus surface antigen screening of blood donations. Trans R Soc Trop Med Hyg (2008) 0.85
[Spotted fever in the Negev]. Harefuah (1982) 0.84
Surveillance of chronic haemodialysis-associated infections in southern Israel. Clin Microbiol Infect (2005) 0.84
Serious bacterial infections after endoscopic procedures. Arch Intern Med (1996) 0.84
Conservative management of implantable cardioverter defibrillator-related endocarditis due to Bacillus spp. Infection (2007) 0.84
Impact of 4% chlorhexidine whole-body washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive care unit. J Hosp Infect (2007) 0.84
[Lassa fever--first case diagnosed in Israel]. Harefuah (1988) 0.84
Post-epidemic serosurvey of West Nile fever in Israel. Eur J Clin Microbiol Infect Dis (2005) 0.83
Q-fever pneumonia in the Negev region of Israel: a review of 20 patients hospitalised over a period of one year. J Infect (1995) 0.83
Failure of ciprofloxacin prophylaxis for ultrasound guided transrectal prostatic biopsy in the era of multiresistant enterobacteriaceae. J Urol (1999) 0.83
Neutrophil superoxide release and interleukin 8 in acute myocardial infarction: distinction between complicated and uncomplicated states. Eur J Clin Invest (1997) 0.83
Infective endocarditis due to Fusobacterium nucleatum in an intravenous drug abuser. Eur J Clin Microbiol Infect Dis (1999) 0.83
Cisplatin-induced bradycardia. Drug Intell Clin Pharm (1983) 0.83
Myeloblastic metamorphosis in lymph node in a case of chronic myeloid leukemia. A clinical, morphological-ultrastructural and cytogenetic study. Haematologica (1982) 0.83
Echis colorata bites: clinical evaluation of 42 patients. A retrospective study. Isr J Med Sci (1986) 0.83
Vitamin C for the treatment of recurrent furunculosis in patients with imparied neutrophil functions. J Infect Dis (1996) 0.82
Hepatitis C virus, autoimmunity and rheumatic disease. Lupus (1997) 0.82
Inhibition of superoxide production in human neutrophils by combinations of heparin and thrombolytic agents. Br Heart J (1995) 0.82
The effects of hypothyroidism on liver status of cirrhotic patients. J Clin Gastroenterol (2000) 0.82
Epstein-Barr virus specific salivary antibodies as related to stress caused by examinations. J Med Virol (2001) 0.82
Immunological studies in angioimmunoblastic lymphadenopathy. Clin Exp Immunol (1980) 0.81
Hepatitis C virus infection and genotypes in Southern Israel and the Gaza Strip. J Med Virol (1998) 0.81
Hemodynamic effects of hypothyroidism induced by methimazole in normal and portal hypertensive rats. Dig Dis Sci (1995) 0.81
Human cytomegalovirus salivary antibodies as related to stress. Clin Lab (2002) 0.81
Membrane binding and release of Bacillus subtilis DNA as a function of the cell cycle. J Gen Microbiol (1988) 0.80
In vitro translation of messenger ribonucleic acid from sporulating and nonsporulating strains of Bacillus subtilis. J Bacteriol (1980) 0.80
Detection and persistence of specific IgA antibodies in serum of patients with hepatitis A by capture radioimmunoassay. J Med Virol (1983) 0.80
Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies. J Viral Hepat (2002) 0.80
Intrinsic potential for high fetal hemoglobin production in a Druz family with beta-thalassemia is due to an unlinked genetic determinant. Hum Genet (1990) 0.80
Sequential therapy with cefuroxime followed by cefuroxime axetil in community-acquired pneumonia. Chest (1997) 0.80